A Silver Compound with Potential Applications as an Anticancer, Antibacterial, Antifungal, and Anti-Alzheimer's Agent      
Yazarlar (7)
Nesrin Korkmaz
Bozok Üniversitesi, Türkiye
Dursun Kısa
Bartin Üniversitesi, Türkiye
Özlem Kaplan
Alanya Alaaddin Keykubat University, Türkiye
Nazan Gökşen Tosun
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Aykut ÖZGÜR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Rizvan Imamoğlu
Bartin Üniversitesi, Türkiye
Ahmet Karadağ
Bozok Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Chemistry and Biodiversity
Dergi ISSN 1612-1872 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili Türkçe
Basım Tarihi 01-2023
Cilt No 20
Sayı 6
DOI Numarası 10.1002/cbdv.202300038
Özet
This study investigated the biological activity of the silver coordination compound K-22. The IC50 values of K-22 on cancer cell lines range from 0.797 μg/mL to 3.426 μg/mL, indicating that K-22 might preferably inhibit A549, Saos-2, MCF-7, and HT-29 cell proliferation and thus have better therapeutic activity. Furthermore, K-22 stimulated apoptosis via up-regulation of the mRNA and protein expression level of Bax/Bcl-2 ratio in A549, Saos-2, MCF-7, and HT-29. K-22 exhibited antimicrobial activity against S. aureus, E. faecalis, K. pneumonia, P. aeruginosa, C. utilis, and C. albicans. Experimental results show that the compound has inhibitory potential with an IC50 value of 178.10 μM for the BChE (butyrylcholinesterase) enzyme, which has a vital role in the progression of Alzheimer's disease. As a result, compound K-22 exhibits a strong potential for medical use due to its anticancer, antibacterial, antifungal, and anti-Alzheimer properties.
Anahtar Kelimeler
anti-Alzheimer's compound | anticancer activity | antimicrobial agents | coordination compound